Patent details

EP2027874 Title: Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment

Basic Information

Publication number:
EP2027874
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP080093628
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
French Title of Invention:
Procédés d'administration/dosage d'anticorps anti-rsv pour la prophylaxie et le traitement
German Title of Invention:
Verfahren zur Verabreichung/Dosierung von Anti-SV-Antikörper zur Prophylaxe und Behandlung
SPC Number:

Dates

Filing date:
28/11/2001
Grant date:
16/10/2013
EP Publication Date:
16/10/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/02/2009
EP B1 Publication Date:
16/10/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/11/2013
Expiration date:
28/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/11/2001
 
 

Name:
MEDIMMUNE INC.
Address:
35 West Watkins Mill Road, Gaithersburg, MD 20878, United States (US)

Inventor

1

Name:
Johnson Leslie S.
Address:
United States (US)

2

Name:
Young James F.
Address:
United States (US)

3

Name:
Koenig Scott
Address:
United States (US)

Priority

1

Priority Number:
724396
Priority Date:
28/11/2000
Priority Country:
United States (US)

2

Priority Number:
724531
Priority Date:
28/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;
Filing date Document type Number of pages